Galectin Therapeutics
GALT
GALT
60 hedge funds and large institutions have $14.8M invested in Galectin Therapeutics in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 61 → 60 (-1)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
Holders
60
Holding in Top 10
–
Calls
$187K
Puts
$30K
Top Buyers
| 1 | +$386K | |
| 2 | +$314K | |
| 3 | +$75.8K | |
| 4 |
HKAM
Horizon Kinetics Asset Management
New York
|
+$63K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$41.5K |
Top Sellers
| 1 | -$271K | |
| 2 | -$173K | |
| 3 | -$52.6K | |
| 4 |
VF
Virtu Financial
New York
|
-$44K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$35.4K |